KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Total Liabilities (2016 - 2025)

Alto Ingredients (ALTO) has 15 years of Total Liabilities data on record, last reported at $166.1 million in Q3 2025.

  • For Q3 2025, Total Liabilities rose 8.2% year-over-year to $166.1 million; the TTM value through Sep 2025 reached $166.1 million, up 8.2%, while the annual FY2024 figure was $176.4 million, 0.97% up from the prior year.
  • Total Liabilities reached $166.1 million in Q3 2025 per ALTO's latest filing, down from $185.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $199.4 million in Q1 2021 and bottomed at $119.7 million in Q3 2022.
  • Average Total Liabilities over 5 years is $168.3 million, with a median of $167.7 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: tumbled 46.16% in 2021, then surged 36.3% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $139.7 million in 2021, then grew by 21.82% to $170.2 million in 2022, then increased by 2.62% to $174.7 million in 2023, then rose by 0.97% to $176.4 million in 2024, then dropped by 5.84% to $166.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $166.1 million in Q3 2025, $185.2 million in Q2 2025, and $188.3 million in Q1 2025.